Form 4 for CVS CVS Health
Accepted 2021-11-19 00:00:00 ET · period of report 2021-11-17 · accession 0001127602-21-029709 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-19 | 2021-11-17 | CVS | SCHAPIRO MARY L | Dir | A - Grant | $92.73 | +417 | 7,585 | +6% | +$38.7K |
| D | 2021-11-19 | 2021-11-17 | CVS | SCHAPIRO MARY L | Dir | A - Grant | $92.73 | +1,254 | 14.6K | +9% | +$116.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-17 | A | A | 417 | $92.73 | 7,585 | D | — | — | (F1) Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. |
| 2 | Derivative | Share Credits | 2021-11-17 | A | A | 1,253.64 | $92.73 | 14,638.12 | D | $0.00 · — to — | 1,253.64 Common Stock | (F2) Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. (F3) Consists of deferred stock compensation payable pursuant to Reporting Person's election. |